Prostate cancer surgery must be endocrine treatment for 1 month

Prostate

cancer is a common malignant tumor. The occurrence and development of the disease are related to androgens. If prostate cancer is large or has high PSA levels, late clinical stage and other risk characteristics, endocrine therapy can be performed before surgery, which can help reduce tumor size, reduce surgery difficulty and improve patient prognosis. However, not every prostate cancer patient needs endocrine therapy before surgery. If prostate cancer is early and the patient is in good health, surgery can be taken directly.